Entirety Biomedical

About Entirety Biomedical

Entirety Biomedical is dedicated to revolutionizing surgical treatment options by creating advanced absorbable metal implants. Their mission is to improve post-surgery patient outcomes with cutting-edge technology that matches the performance of traditional titanium implants while safely absorbing after healing, eliminating lifelong complications and discomfort associated with permanent hardware.

Products & Services

Curasorb Alloy Technology:An absorbable metal implant technology designed for surgeons and patients, offering performance reliability and simple implantation like titanium implants, but safely absorbs after healing. Used in cosmetic, trauma, and reconstruction procedures.

Specialties

Absorbable Metal Implants Surgical Fixation Technology Post-Surgery Patient Outcomes

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 1200000 MR: - FA: 1.2 million FAN: 1200000	D: 2026-02-11 FD: 2026-02-11	7 investors

Seed Latest

2026-02-11

$1.2M

7 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jake Edick

CEO and Co-Founder

LinkedIn (Pro only)

C

Carolyn Woldring

CTO and Co-Founder

LinkedIn (Pro only)

A

Amy Ghelardi

Chief Commercial Officer

LinkedIn (Pro only)

M

Markus Kuhn

Product Development Lead

C

Christian Knöpfle

Product Design Lead

N

Neal Magnuson

Sr. Product Development Engineer

View 8 more team members with Pro

Unlock Full Team Directory

Recent News